features and various viral serologies in patients who underwent hepatectomy in the treatment of hepatocellular carcinoma (HCC).
Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection
β Scribed by Ken Shirabe; Mitsuo Shimada; Kiyoshi Kajiyama; Tomonobu Gion; Yasuharu Ikeda; Hirofumi Hasegawa; Kenichi Taguchi; Kenji Takenaka; Keizo Sugimachi
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 80 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND.
This study was performed to clarify the clinicopathologic features of hepatocellular carcinoma (HCC) patients surviving ΟΎ10 years after hepatic resection.
METHODS.
Between January 1971 and April 1987, 142 patients underwent hepatic resection. Thirty-nine patients who died of surgical morbidity (surgical mortality rate: 27.5%) were excluded from this study. Among the 103 patients who survived and were observed for ΟΎ10 years after surgery, 12 patients (11.7%) survived ΟΎ10 years after hepatectomy. The surviving patients were divided into 2 groups: 10-year survivors (n Ο 12) and nonsurvivors (n Ο 91). A comparative study between the two groups was made.
π SIMILAR VOLUMES
## Background: Risk factors for recurrence after resection of hepatitis b virus (hbv)-related hepatocellular carcinoma (hcc) require more precise definition. ## Methods: Forty patients who underwent liver resection for hbv-related hcc were studied. their clinical findings, laboratory data (includ
## Background and Objectives: The 5-year survival rates after resection of pancreatic carcinoma have recently increased and are predicted by tumor size, DNA content, and lymph node metastases at the time of resection. However, whether the 10-year survival rates have also increased and are similarl
The authors are grateful for the cooperation of all study participants and collaborators in the original study and to Chiara Zappitello for editorial assistance. They are indebted to Claudio Coppi (ARPAT, Pistoia, Italy) for providing DMA and NDMA concentrations in local foods, to Giovanna Cordopatr
## BACKGROUND. Transcatheter arterial chemoembolization (TACE) has been used as a palliative treatment for patients with unresectable hepatocellular carcinoma (HCC), but its prognostic usefulness has not previously been clarified. ## METHODS. The authors reviewed all patients treated at their ins